Intellia Therapeutics, Inc.
NTLA
$13.55
$0.070.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.21% | -22.35% | -33.49% | -36.34% | -34.06% |
| Total Receivables | 11.17% | 24.80% | -7.92% | -71.16% | -76.64% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 129.15% | 35.82% | -53.65% | -34.06% | -37.27% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -17.53% | -18.14% | -34.50% | -37.63% | -35.91% |
|
|
|||||
| Total Current Assets | -17.53% | -18.14% | -34.50% | -37.63% | -35.91% |
| Net Property, Plant & Equipment | -49.88% | 7.13% | 11.91% | 14.46% | 66.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -24.79% | -0.85% | 222.02% | 147.75% | -4.03% |
| Total Assets | -29.29% | -21.14% | -24.56% | -21.71% | -8.45% |
|
|
|||||
| Total Accounts Payable | 38.82% | 0.87% | -47.91% | -9.68% | 95.77% |
| Total Accrued Expenses | -9.92% | -18.08% | -2.91% | 3.88% | -7.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.79% | 42.76% | 42.33% | 106.59% | 8.86% |
| Total Finance Division Other Current Liabilities | -64.72% | -47.89% | -30.02% | -21.08% | -28.83% |
| Total Other Current Liabilities | -64.72% | -47.89% | -30.02% | -21.08% | -28.83% |
| Total Current Liabilities | -6.29% | -11.31% | -9.13% | 14.99% | -3.78% |
|
|
|||||
| Total Current Liabilities | -6.29% | -11.31% | -9.13% | 14.99% | -3.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -64.81% | -14.38% | -13.43% | -12.61% | 96.34% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -44.53% | -55.30% | -60.64% | -53.01% |
| Total Liabilities | -46.49% | -16.08% | -16.71% | -7.70% | 27.21% |
|
|
|||||
| Common Stock & APIC | 6.94% | 7.78% | 7.72% | 9.55% | 12.47% |
| Retained Earnings | -18.95% | -21.76% | -25.10% | -29.78% | -31.30% |
| Treasury Stock & Other | 70.58% | -69.97% | 156.54% | 211.62% | 126.79% |
| Total Common Equity | -23.00% | -22.25% | -26.34% | -24.73% | -16.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.00% | -22.25% | -26.34% | -24.73% | -16.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.00% | -22.25% | -26.34% | -24.73% | -16.97% |
|
|
|||||